Table of Contents Table of Contents
Previous Page  237 / 330 Next Page
Information
Show Menu
Previous Page 237 / 330 Next Page
Page Background

237

19–22 APRIL, 2017, BARCELONA, SPAIN

S22: STONES

Moderators: Juan P. Corbetta (Argentina), Henri Lottmann (France)

ESPU Meeting on Saturday 22, April 2017, 10:20–11:02

10:20–10:23

S22-1 (PP)

IMBALANCE IN URINARY PROTEOGLYCANS

AND THE INSULIN GROWTH FACTOR (IGF) AXIS

IN CHILDREN WITH UROLITHIASIS

Larisa KOVACEVIC

1

, Hong LU

1

, Joseph A. CARUSO

2

, Ronald THOMAS

3

and Yegappan LAKSHMANAN

1

1) Children’s Hospital of Michigan, Pediatric Urology, Detroit, USA - 2) Institute of Environmental Health Sciences,

Wayne State University, Proteomics, Detroit, USA - 3) Children’s Hospital of Michigan, Wayne State University, Statistics,

Detroit, USA

PURPOSE

Based on the role of the extracellular matrix (ECM) in the Randall plaque formation, we aimed to

identify and quantify ECM proteins in the urine of children with urolithiasis (RS) using a proteomic

approach.

MATERIAL AND METHODS

Prospective, controlled, pilot study of pooled urine from RS (N=30, 24 females, mean age

12.95±4.03 years) versus age- and gender-matched healthy controls (HC), using mass spectrom-

etry. Relative protein abundance was estimated using spectral counting. The criteria for protein

selection were: 1) ≥5 spectral counts; 2) ≥2-fold difference in spectral counts; and 3) ≤0.05 p-value

for the Fisher’s Test. Results were confirmed by ELISA.

RESULTS

We found 36 (15.7%) ECM proteins out of 229 that met the above criteria. Significant differences

between RS and HC were found among two proteoglycans and four insulin growth factor (IGF)

proteins (Table). Significant increase in the urinary excretion of IGFBP4 in RS versus HC was

confirmed by ELISA (p=0.001).

Accession

Number

Protein

Assigned peptides Ratio

(Patient/Control)

PRG4

Proteoglycan 4

38 (5)

7.6*

SDC1

Heparan sulfate proteoglycan

(Syndecan 1)

5 (50)

0.1*

IGF2R

Cation-independent mannose-6-phosphate

receptor

2 (13)

0.15*

IGFBP1

Insulin-like growth factor-binding protein 1 8 (0)

Unique

IGFBP4

Insulin-like growth factor-binding protein 4 17 (4)

4.2*

IGFBP6

Insulin-like growth factor-binding protein 6 49 (2)

24.5*

*P<0.01

CONCLUSIONS

Alteration in proteoglycans and the IGF axis appears to have a significant role in the mechanism of

urolithiasis, likely by modulating ECM biosynthesis. Further understanding of their roles in urolithi-

asis may aid in generation of novel therapeutic approaches.